A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder

Journal of Clinical Psychiatry

Volumn 57, Issue 5, 1996, Pages 213-222

  Keck Jr , Paul E ^a   Nabulsi, Azmi A ^b   Taylor, Jennifer L ^c   Henke, Curtis J ^c,d   Chmiel, Joseph J ^b   Stanton, Sean P ^a   Bennett, Jerry A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b ABBOTT LABORATORIES   (United States)

^c Technology Assessment Group   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; VALPROATE SEMISODIUM;

ARTICLE; COST BENEFIT ANALYSIS; DRUG ACTIVITY; DRUG COST; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROPHYLAXIS;

ACUTE DISEASE; AMBULATORY CARE; BIPOLAR DISORDER; COSTS AND COST ANALYSIS; DECISION SUPPORT TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LITHIUM; RECURRENCE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0029952221     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Robins LN, Regier DA, eds. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York, NY: Free Press; 1991
2. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19
3. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990
4. Solomon DA, Keitner GI, Miller IW, et al. Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiatry 1995; 56:5-13
5. Dion GL, Tohen M, Anthony WA, et al. Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Community Psychiatry 1988;39:652-657
6. Tohen M, Waternaux CS, Tsuang MT. Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990;47:1106-1111
7. Prien RF, Gelenberg AJ. Alternatives to lithium for preventative treatment of bipolar disorder. Psychopharmacol Bull 1990;26:409-427
8. United States Department of Health, Education and Welfare. Medical Practice Project: a State-of-the-Science Report for the office of the Assistant Secretary for the US Department of Health, Education and Welfare. Baltimore, Md: Policy Research; 1979
9. Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405-418
10. Prien RF, Potter WZ. NIMH workshop report on treatment of bipolar disorder. Psychopharmacol Bull 1990;26:409-427
11. Dilsaver SC, Chen Y-W, Swan AC, et al. Suicidality in patients with pure and depressive mania. Am J Psychiatry 1994;151:1312-1315
12. Keck PE Jr, McElroy SL, Nemeroff CB. Anticonvulsants in the treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci 1992;4:395-405
13. Hirschfeld RMA, Clayton PJ, Cohen I, et al. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994;151 (suppl):1-36
14. Keck PE Jr, Bennett JA, Stanton SP. Health-economic aspects of the treatment of manic-depressive illness with divalproex. Reviews in Contemporary Pharmacotherapy 1995;6:597-604
15. Keck PE Jr, McElroy SL, Tugrul KC, et al. Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993;54:305-308
16. McElroy SL, Keck PE Jr, Tugrul KC, et al. Valproate as a loading treatment in acute mania. Neuropsychobiology 1993;27:146-149
17. McElroy SL, Keck PE Jr, Pope HG Jr, et al. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992;149:1633-1644
18. Dunner DL, Fieve RR. Clinical factors in lithium prophylaxis failure. Arch Gen Psychiatry 1974;30:229-233
19. Freeman TW, Clothier JL, Pazzaglia P, et al. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992;149:108-111
20. Bowden CL, Bruger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271:918-924
21. McElrey SL, Keck PE Jr, Pope HG Jr, et al. Treatment of rapid cycling bipolar disorder with sodium valproate. J Clin Psychopharmacol 1988;8:275-279
22. Calabrese JR, Markovitz PJ, Kimmel SE, et al. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 1992;12(suppl):53-56
23. Bentkover JD, Baker AM, Kaplan H. Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol. Pharmaco Economics 1994;5:335-342
24. Le Pen C, Levy E, Ravily V, et al. The cost of treatment dropout in depression: a cost-benefit analysis of fluoxetine vs tricyclics. J Affect Disord 1994;31:1-18
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980
26. Keck PE Jr, McElroy SL, Strakowski SM, et al. Outcome and comorbidity in first compared with multiple-episode mania. J Nerv Ment Dis 1995; 183:320-324
27. McElroy SL, Strakowski SM, Keck PE Jr, et al. Differences and similarities in mixed and pure mania. Compr Psychiatry 1995;36:187-194
28. Pope HG Jr, McElroy SL, Keck PE Jr, et al. Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991;48:62-68
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987
30. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-III-R, Patient Version (SCID-P). New York, NY: Biometric Research, New York State Psychiatric Institute; 1990
31. Williams JBW, Gibbon M, First MB, et al. The Structured Clinical Interview for DSM-III-R (SCID), II: multisite test-retest reliability. Arch Gen Psychiatry 1992;49:624-630
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
33. Lambert PA, Venaud G. Comparative study of valpromide versus lithium as prophylactic treatment in affective disorders. Nerv J Psychiatrie 1995;7:1-9
34. Lyle JR, Torras HW, Jones H. 1994 Physicians Fee and Coding Guide. Augusta, Ga: Healthcare Consultants of America; 1994
35. Health Care Financing Administration. Charge-based practice and malpractice expense RVUs in 1994, based on 1992 data. Federal Register, May 24, 1993;58:63626-63854
36. Hsiao WC, Braun P, Yntema D, et al. Estimating physicians' work for a resource-based relative value scale. N Engl J Med 1988;319:835-841
37. State of California, Office of Statewide Health Planning and Development. Hospital Discharge Database. Sacramento, Calif: State of California; 1990
38. US Bureau of Labor Statistics. Monthly Labor Review and CPI Detailed Report. US Bureau of Labor Statistics, Office of Prices and Living Conditions, May 11, 1995. Washington, DC: US Government Printing Office
39. Garrett HM, ed. 1994 Red Book Pharmacy's Fundamental Reference. Montvale, NJ: Medical Economics Data Production Company; 1994
40. Levit KR, Cowan CA, Lazenby HC, et al. National Health Spending Trends, 1960-1993. Health Aff 1994;13:14-31